Hematopathology Rotation (AP-2)
- Dr. David Hudnall
- Dr. Demetrios Braddock
The resident is crucial to this service, organizing all information regarding wet hematologic cases and initiating phenotyping and genotyping studies on lymphomas. A wide spectrum of material, both in-house and consultative, is available due to the variety of patients attracted to YNHH. Thus, residents experience diverse exposure to histologic material and become conversant in the rapidly evolving field of molecular hematopathology. Residents also have access to a vast teaching collection. Evaluation and constant guidance are ongoing. The goal of this rotation is to assure adequate exposure in hematopathology for general surgical pathologists as well as to afford a very strong foundation for those residents wishing to specialize in this field.
Ancillary studies are integral to the workup of most hematopathology cases. The resident will be expected to participate in the evaluation of all components of a case, including those portions performed in Laboratory Medicine. This rotation, thus, routinely bridges the AP and CP training experiences.
Additional Resident Duties and Responsibilities
- Attend the weekly hematology/oncology conference
- When not handling cases in surgical pathology, participate in the evaluation of other parts of these cases in Laboratory Medicine
Additional Goals and Objectives for the Hematopathology Rotation
- Become proficient in the standard techniques for the gross evaluation, dictation, and dissection of lymph node/spleen specimens, paying particular attention to issues of diagnostic and prognostic significance.
- Understand techniques commonly used in working up hematopathology cases such as classic morphology, immunohistochemistry, flow cytometry, FISH, cytogenetics, EM, frozen section, smears, and touch preparations.
- Understand the clinical and pathologic criteria used to distinguish reactive from malignant lymph nodes, phenotype and genotype lymphomas, apply cytogenetic results to diagnoses, stage lymphomas, diagnose etiologies for anemia, understand myelodysplastic syndromes and leukemias, and evaluate the effects of treatment and therapy on lymph node, splenic, and bone marrow pathology